Hayashi H, Toki J, Zhexiong L, Sugiura K, Inoue K, Ikehara S
First Department of Pathology, Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Stem Cells. 2000;18(4):273-80. doi: 10.1634/stemcells.18-4-273.
We examined the induction of tolerance using pancreas allografts over the long term (>1 year) in mice for the human application of mixed allogeneic bone marrow transplantation (BMT). T cell-depleted BM cells (BMCs) of C57BL/6 (B6) and C3H/He (C3H) mice were transplanted at various ratios into lethally irradiated B6 mice. The percentages of C3H cells in the chimeric mice gradually decreased, finally declining to only a small percentage, except when the ratio of donor to recipient BMCs was 100:1. However, despite the marked decreases in C3H-type cells, all the pancreas allografts of C3H mice were accepted when more than 1% C3H cells were detected in the peripheral blood. To examine the relationships between percentages of transplanted donor cells and acceptance of pancreas allografts, various percentages of donor and recipient BMCs (5% to 30%) were transplanted. It was found that more than 10% donor cells were necessary for the pancreas allografts to be accepted. In vitro assays for mixed lymphocyte reaction and generation of cytotoxic T-lymphocytes revealed that spleen cells in chimeric mice accepting pancreas allografts are tolerant to both host-type and donor-type major histocompatibility complex (MHC) determinants, but show a vigorous responsiveness to third-party MHC determinants. Since donor-type hemopoietic stem cells (HSCs) were detected in the BM and the liver of the chimeric mice, donor-derived HSCs and donor-derived hematolymphoid cells are responsible for the induction of tolerance. It should be noted that the percentage of donor-type HSCs is higher in the liver (6.2%) than in the BM (0.9%).
我们研究了在小鼠中长期(>1年)使用胰腺同种异体移植诱导耐受性,以用于人类混合同种异体骨髓移植(BMT)。将C57BL/6(B6)和C3H/He(C3H)小鼠的T细胞去除的骨髓细胞(BMC)以不同比例移植到经致死剂量照射的B6小鼠中。嵌合小鼠中C3H细胞的百分比逐渐降低,最终降至仅一小部分,除非供体与受体BMC的比例为100:1。然而,尽管C3H型细胞显著减少,但当外周血中检测到超过1%的C3H细胞时,C3H小鼠的所有胰腺同种异体移植均被接受。为了研究移植供体细胞百分比与胰腺同种异体移植接受情况之间的关系,移植了不同百分比的供体和受体BMC(5%至30%)。发现胰腺同种异体移植被接受需要超过10%的供体细胞。混合淋巴细胞反应和细胞毒性T淋巴细胞生成的体外试验表明,接受胰腺同种异体移植的嵌合小鼠中的脾细胞对宿主型和供体型主要组织相容性复合体(MHC)决定簇均具有耐受性,但对第三方MHC决定簇表现出强烈的反应性。由于在嵌合小鼠的骨髓和肝脏中检测到了供体型造血干细胞(HSC),供体来源的HSC和供体来源的血液淋巴细胞负责耐受性的诱导。应当注意的是,供体型HSC在肝脏中的百分比(6.2%)高于骨髓中的百分比(0.9%)。